Noxopharm (NOX) Short Interest
Noxopharm (ASX:NOX) had 0.00% of shares reported as short positions as of 10 Aug 2026, representing 7,883 shares. Noxopharm operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Noxopharm
Noxopharm Limited is an Australian clinical-stage drug development company focused on creating innovative treatments for cancer and cytokine release syndrome (septic shock). The company is dedicated to improving patient outcomes through novel therapies and has a pipeline of drug candidates targeting unmet medical needs in oncology and inflammation.
Short position
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4NOX intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Noxopharm
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss NOX
Start a research thread or post the first pulse update